Resultados de la búsqueda 1161-1170 of 11271 for Epilepsy (Partial Onset)
The purpose of this study is to evaluate the effect of immunotherapy drugs (ipilimumab and nivolumab) in treating patients with glioblastoma that has come ...
Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...
Los antidepresivos son la materia prima del tratamiento de muchas afecciones de dolor crónico, como la artritis, la lesión a los nervios, el dolor de cabeza ...
Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the growth ...
Additinoally, to evaluate the effectiveness by overall response rate (ORR – defined as confirmed and unconfirmed partial responses plus complete responses) ...
... onset of therapy. A Study to Evaluate Daratumumab/rHuPh20 +/- Lenalidomide ... Duration. Rochester, Minn., Eau Claire, Wis., Scottsdale/Phoenix, Ariz ...
Scottsdale/Phoenix, Ariz. The main objective of the Brain Tumor Repository is to allow access to coded patient data by researchers both inside and outside of ...
This study is being conducted to see if adding Exemestane to the immune checkpoint blockade can slow disease progression in post-menopausal women with non-small ...
The study hypothesis is that the progressively increased interval duration ... appearance/symptoms, and impact on quality of life)?. A Study to Establish a ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?